Health
Nasal spray to fight COVID-19 could be manufactured in Australia – Manufacturers’ Monthly
A nasal treatment for COVID-19, common colds and flu is being taken to the next stage of testing, backed by the $500 million Biomedical Translation Fund.
A nasal treatment for COVID-19, common colds and flu is being taken to the next stage of testing, with backing from the federal government’s $500 million Biomedical Translation Fund.
Developed by Australian biotech company Ena Respiratory, INNA-051 works by stimulating the innate immune system, the first line of defence against the invasion of pathogens into the body.
The government, with Brandon Capital Partners has committed $11.7 million to test the nasal spray treatment, that targets the primary…
-
Noosa News22 hours agoMan dies after stabbing in inner-city unit
-
General23 hours agoCheap batteries pledge powers Labor re-election push
-
Noosa News17 hours agoMeasles alert issued across popular south-east attractions
-
General11 hours agoCoalition abandons ‘end’ to work from home, walks back 41,000 job cuts